Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cisplatin Chemoradiotherapy vs Radiotherapy Alone for Intermediate-risk SCCHN
NCT07125755Phase 3Recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Aug 2025
- Primary completion
- Aug 2028
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Cisplatin micelle injection (HA132) in head and neck squamous cell carcinoma (HNSCC), sponsored by Sun Yat-sen University. Started Aug 2025; status: recruiting.
02
Drugs
Cisplatin micelle injection (HA132)
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT07125755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07125755.